(MedPage Today) — Use of tirzepatide (Mounjaro, Zepbound) was tied to a reduced incidence of new or progressive diabetic retinopathy and fewer complications in patients with diabetes and overweight/obesity, a retrospective study suggested.
In…
Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/119621
Author :
Publish date : 2026-01-28 14:47:00
Copyright for syndicated content belongs to the linked Source.
